Exact Mass: 358.1966

A dihydroxybenzoic acid that is olivetolic acid in which the hydrogen at position 3 is substituted by a 3-p-mentha-1,8-dien-3-yl (limonene) group.

GELSEMICINE

NCIOpen2_008042

Estra-1,3,5(10),16-tetraen-3-ol benzoate

C25H26O2 (358.1933)

NCIOpen2_007663

3-Methoxy-16-methylestra-1,3,5(10)-triene-16beta,17beta-diol 17-acetate

3,11-dioxoandrost-4-en-17-yl propionate

17beta-Hydroxyandrost-4-ene-3,11-dione propionate

delta9-tetrahydrocannabinolic acid

Sorgoleone 358

2-hydroxy-5-methoxy-3-[(8E,11E)-pentadeca-8,11,14-trien-1-yl]cyclohexa-2,5-diene-1,4-dione

Sorgoleone 358 is found in cereals and cereal products. Sorgoleone 358 is a constituent of the etiolated seedlings of Sorghum bicolor (sorghum). Constituent of the etiolated seedlings of Sorghum bicolor (sorghum). Sorgoleone 358 is found in cereals and cereal products and sorghum.

Piperoic acid

3,4-dihydroxy-5-[(2E,6Z)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]benzoic acid

Piperoic acid is found in herbs and spices. Piperoic acid is a constituent of the leaves of Piper auritum (Veracruz pepper). Constituent of the leaves of Piper auritum (Veracruz pepper). Piperoic acid is found in herbs and spices.

11,12-Dimethoxy-8,11,13-abietatrien-20,7-olide

3,4-dimethoxy-11,11-dimethyl-5-(propan-2-yl)-16-oxatetracyclo[6.6.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5-trien-15-one

11,12-Dimethoxy-8,11,13-abietatrien-20,7-olide is found in beverages. 11,12-Dimethoxy-8,11,13-abietatrien-20,7-olide is a constituent of Salvia columbariae (California chia)

3,3'-Di-tert-butyl-5,5'-dimethoxybiphenyl-2,2'-diol

3,3-di-tert-butyl-5,5-dimethoxy-[1,1-biphenyl]-2,2-diol

2-(3,7,11-Trimethyldodeca-2,6,10-trienylsulfanyl)benzoic acid

2-[(3,7,11-Trimethyldodeca-2,6,10-trien-1-yl)sulphanyl]benzoic acid

9-Carboxy-thc

1-hydroxy-6,6,9-trimethyl-3-pentyl-6H,6aH,7H,8H,10aH-benzo[c]isochromene-2-carboxylic acid

4,4'-Thiobis(6-tert-butyl-m-cresol)

2-tert-butyl-4-[(5-tert-butyl-4-hydroxy-2-methylphenyl)sulfanyl]-5-methylphenol

Cannabidiolic acid

2,4-dihydroxy-3-[3-methyl-6-(prop-1-en-2-yl)cyclohex-2-en-1-yl]-6-pentylbenzoic acid

Canrenoic acid

3-{14-hydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-6,8-dien-14-yl}propanoic acid

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000451 - Mineralocorticoid Receptor Antagonists D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics

Ferutinin

3-Hydroxy-6,8a-dimethyl-3-(propan-2-yl)-1,2,3,3a,4,5,8,8a-octahydroazulen-4-yl 4-hydroxybenzoic acid

Ferutinin, a natural terpenoid compound, is an estrogen receptor ERα agonist and estrogen ERβ-receptor agonist/antagonist with IC50s of 33.1 nM and 180.5 nM, respectively. Ferutinin acts as an electrogenic Ca2+-ionophore that increases calcium permeability of lipid bilayer membranes, mitochondria. Ferutinin possesses estrogenic, antitumor, antibacterial and antiinflammatory activities[1][2].

Itopride

N-({4-[2-(dimethylamino)ethoxy]phenyl}methyl)-3,4-dimethoxybenzene-1-carboximidate

A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor

Rislenemdaz

(4-Methylphenyl)methyl 3-fluoro-4-{[(pyrimidin-2-yl)amino]methyl}piperidine-1-carboxylic acid

C19H23FN4O2 (358.1805)

3-Dehydroxyl-20-acetylpresinularolide B

(+)-3-Dehydroxyl-20-acetylpresinularolide B

Kuhistanol G

BE 40644

XR 368

Bengamide E

C17H30N2O6 (358.2104)

MLS004491785

18-Oxoaustrochaparol acetate

Hippochromin A

phyllospinarone

21-Hydroxy-19-methoxyarenarone

Cannabichromenic acid

5-hydroxy-2-methyl-2-(4-methylpent-3-enyl)-7-pentylchromene-6-carboxylic acid

A chromenol that is 2H-chromene substituted by methyl, 2-methylpent-2-en-5-yl, hydroxy, carboxy and pentyl groups at positions 2,2,5,6 and 7, respectively.

delta9-tetrahydrocannabinic acid

delta9-tetrahydrocannabinolic acid

Itopride

Ferutinin

Jaeschkeanadiol p-hydroxybenzoate

4,4-Thiobis(2-(tert-butyl)-5-methylphenol)

Binospirone

C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

4-hydroxy-2,5,5,9-tetramethylcycloundeca-2,9-dienyl 4-hydroxybenzoate

relative retention time with respect to 9-anthracene Carboxylic Acid is 1.449 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.453 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.451

Myrsinoic acid B

A member of the class of 1-benzofurans that is 2,3-dihydro-1-benzofuran substituted by a carboxy group at position 5, a 1,5-dimethyl-1-hydroxy-4-hexenyl group at position 2 and a prenyl group at position 7. Isolated from Myrsine seguinii, it exhibits anti-inflammatory activity.

Yohimbic acid (hydrate)

4-hydroxy-3-[(2E,6E)-4-hydroxy-3,7,11-trimethyldodeca-2,6,10-trienyl]benzoic acid

(6E,10E)-isopolycerasoidol|isopolycerasoidol

Kericembrenolide B

dactylospongiaquinone

ent-8,9-seco-7alpha-acetoxykaura-8(14),16-dien-9,15-dione|ent-8,9-Seco-7??-acetoxykaura-8(14),16-dien-9,15-dione

Smenoqualone

CYCLOSPONGIAQUINONE-1

5-Methoxy-2-hydroxy-3-(1,2,4a-trimethyl-5-methylenedecalin-1-ylmethyl)-1,4-benzoquinone

9-(3,4-dihydro-7-hydroxy-2,5-dimethyl-2h-benzopyran-2-yl)-2,6-dimethyl-2,6-nonadienoic acid

4-oxomacrophorin D

12-oxoisospongia-13,15-dien-20-yl acetate|20-acetoxymarginatone

indoxamycin C

neomamanuthaquinone

C22H30O4

Siphonodictyal B

8-(4-Hydroxybenzoyl)-4,6-Germacradiene-8,10-diol

(3S,4aS,10aS)-1,2,3,4,4a,9,10,10a-octahydro-6-hydroxy-7-isopropyl-1,1,4a-trimethyl-9-oxophenanthren-3-yl acetate|2alpha-acetoxysugiol

Ircinin-3-methylester

2-(4-Methoxy-3-methyl-6-isopropylphenoxy)-4-methoxy-3-methyl-6-isopropylphenol

indoxamycin F

1-[7,8-dihydro-7-hydroxy-7-methyl-8-oxo-3-(1E)-1-propenyl-6H-2-benzopyran]undecan-2-one|rubropunctin

Ircinin-4-methylester

Dictyoceratidaquinone

12-acetylroyleanone|12-O-Acetoxy-royleanon|7-acetyl-royleanone|Royleanone Acetat

Cannabicyclolic acid

tridachiapyrone G, H

SCHEMBL18908992

exserifolin F

Gesneroidin B

Tridachion|Tridachione

3-acetoxyhelioscopinolide B|3beta-Acetoxy-Helioscopinolide B

MS000089461

(-)-(1betaH,7E)-6-beta-acetoxyverticilla-4(18),7,11-triene-10,12-gamma-lactone|(5R,10S,11E,13aR)-2,4,5,6,7,8,9,10,13,13a-decahydro-4,4,12-trimethyl-8-methylidene-2-oxo-3,5-ethanocyclododeca[b]furan-10-yl acetate|cespihypotin Y

(-)-(1betaH,7E)-6-beta-acetoxyverticilla-4(18),7,11-triene-10,12-gamma-lactone|(5R,10S,11E,13aR)-2,4,5,6,7,8,9,10,13,13a-decahydro-4,4,12-trimethyl-8-methylidene-2-oxo-3,5-ethanocyclododeca[b]furan-10-yl acetate|cespihypotin Y

(+)-hyatellaquinone|3-[[(1R,4aR,8aR)-decahydro-5,5,8a-trimethyl-2-methylene-1-naphthalenyl]methyl]-2-hydroxy-5-methoxy-2,5-cyclohexadiene-1,4-dione|3-{[(1R,4aR,5R,8aR)-decahydro-5,5,8a-trimethyl-2-methylenenaphthalen-1-yl]methyl}-2-hydroxy-5-methoxycyclohexa-2,5-diene-1,4-dione|hyatellaquinone

(+)-hyatellaquinone|3-[[(1R,4aR,8aR)-decahydro-5,5,8a-trimethyl-2-methylene-1-naphthalenyl]methyl]-2-hydroxy-5-methoxy-2,5-cyclohexadiene-1,4-dione|3-{[(1R,4aR,5R,8aR)-decahydro-5,5,8a-trimethyl-2-methylenenaphthalen-1-yl]methyl}-2-hydroxy-5-methoxycyclohexa-2,5-diene-1,4-dione|hyatellaquinone

3-farnesyl-4-hydroxybenzoic acid

19-acetoxy-15,16-epoxy-8(17),13(16),14-ent-labdatrien-20-al

2,3-epoxy-jaeschkeanadiol benzoate|epoxybenz|epoxyferutinol benzoate|epoxyjaeschkeanadiol benzoate

Methyl capucinoate A

Kempen-1

6alpha-hydroxy-7beta-acetoxyvouacap-14(17)-ene

(2S,3S)-6-carboxy-2,3-dihydro-3-hydroxy-2-methyl-2-(4-methylpenta-3-enyl)-8-(3-methyl-2-butenyl)chroman|myrsinoic acid C

indoxamycin E

5-O-acetyl-13-deacetoxy-guanacastepene A|heptemerone G

Metachromin C

Delta-9-Tetrahydrocannabinolic acid

Isobengamide E

C17H30N2O6 (358.2104)

17-acetoxy-15,16-epoxyisocleistanth-12-en-11-one

2-[2-(5-hydroxy-2,7-dimethyl-2H-chromen-2-yl)-ethyl]-3,3-dimethyl-cyclohexanecarboxylic acid|Siccanochromen-G|Siccanochromene-G

Kericembrenolide A

12-formyl-11-hydroxy-8,11,13-abietatrien-2-oic acid methylester

CJ-13,981

ferruginene A

Tmndga

2-farnesyl-3,4-dihydroxybenzoic acid

(1S,2S,11S*,3E,7E,12Z)-11-acetoxycembra-3,7,12(13),15(17)-tetraen-16,2-olide|crassocolide P

(1S*,2S*,11S*,3E,7E,12Z)-11-acetoxycembra-3,7,12(13),15(17)-tetraen-16,2-olide|crassocolide P

4beta,9alpha-dihydroxy-6alpha-benzoyl-dauc-7-ene|lancerotriol benzoate

alstonoxine C

(2R,13Z)-2-acetoxy-10-oxo-4,10-secospata-2,13(15),17-trien-12-al

Erionic acid F

indoxamycin D

4-hydroxy-3-((E)-4-hydroxy-3,7-dimethyl-octa-2,6-dienyl)-5-(3-methyl-but-2-enyl)-benzoic acid

manadoperoxide I

16-acetoxylsugiol

5-Acetyl-2,3-dihydrobenzofuran 2-(2-methyleneethanol)nonanoate

4beta,8beta-dihydroxy-6alpha-benzoyldauc-9-ene|feruhermonin B

(?)-secoisolariciresinol

dysoxydenone L

Siphonodictyal C

elisabethin A acetate

SCHEMBL15342390

siphonodictyal-B

5-hydroxy-2,6,8-trimethyl-8-(3,7-dimethyl-2,6-octadienyl)-2H-1-benzopyran-4,7(3H,8H)-dione

Metachromin E

cyclospongiaquinone-2

12beta-Hydroxy-16alpha-methoxy-pregna-4,6-dien-3,20-dion

Mamanuthaquinone

6-O-acetylcespitularin F|cespitularin J

Ac-(5alpha,10alpha,11beta,13alpha)-5,10-Epoxy-11-hydroxy-1,15-rosadien-3-one

Gelselegine

Di-Me ester-8,11,13-Cleistanthatriene-17,19-dioic acid

(5R,13Z)-5-acetoxy-10-oxo-4,10-secospata-2,13(15),17-trien-12-al|(5R,13Z)-5.acetoxy-10-oxo-4,10-secospata-2,13(15),17-trien-12-al

2-hydroxy-4-methoxy-3-{[(2S,4aS,8aS)-octahydro-2,5,5,8a-tetramethylnaphthalen-1(2H)-ylidene]methyl}cyclohexa-2,5-diene-1,4-dione|Spongiachinon|Spongiaquinone

20-Hydroxydihydrorankinidine

irciformonin A|rel-(2R,2S,5S)-5-[(1E,4E)-7-(furan-3-yl)-4-methylhepta-1,4-dien-1-yl]hexahydro-2,5-dimethyl-[2,2-bifuran]-5(2H)-one

globostelletin F|LJRG-105

19-acetoxyspongia-13(16),14-dien-3-one

SCHEMBL352522

perrottetin C trimethyl ether

jaeskeanadiol salicylate

Siphonodictyoic acid

ent-(5beta,8alpha,9beta,10alpha,11alpha,12alpha)-3,14-dioxoatis-16-en-11-yl acetate

dilopholide

SCHEMBL18909013

indoxamycin B

CPB-2004-52-608-2

gelsenine

Mediterraneone

linalool-beta-D-glucopyranoside-2O-acetate

(-)-(4S,5S,10R,20R)-12,18-dihydroxy-7-oxo-abieta-8,11,13-trien-20-aldehyde 18,20-ethyl acetal

An abietane diterpenoid isolated from the stem bark of Fraxinus sieboldiana.

PETIOLIN A

5-epi-ilimaquinone

A natural product found in Dactylospongia elegans.

15-keto Iloprost

6,9α-methylene-11α-hydroxy-15-keto-16-methyl-prosta-5E,13E-dien-18-yn-1-oic acid

Pro Lys Asp

S-Farnesylthiosalicylic acid;Farnesyl Thiosalicylic Acid;FTS

serylprolylarginine

aspartylprolyllysine

Lys Pro Asp

Pro Arg Ser

Arg Pro Ser

prolylaspartyllysine

CHEBI:143459

CAFESTOL ACETATE

prolylserylarginine

yohimbinic acid

(1R,2S,4aR,13bS,14aS)-2-hydroxy-1,2,3,4,4a,5,7,8,13,13b,14,14a-dodecahydroindolo[2,3:3,4]pyrido[1,2-b]isoquinoline-1-carboxylic acid hydrate

Yohimbic acid hydrate is an amphoteric demethylated derivative of Yohimbine (HY-12715). Yohimbic acid hydrate exhibits vasodilatory action. Yohimbic acid hydrate also can be used for the research of osteoarthritis (OA)[1][2][3].

Juniferdin

[(1R,2Z,4S,9Z)-4-hydroxy-2,5,5,9-tetramethylcycloundeca-2,9-dien-1-yl] 4-hydroxybenzoate

Tefestrol

Benzoic acid, 4-hydroxy-, 1,2,3,3a,4,5,8,8a-octahydro-3-hydroxy-6,8a-dimethyl-3-(1-methylethyl)-4-azulenyl ester, (3R-(3alpha,3abeta,4beta,8aalpha))-

Ferutinine is a natural product found in Ferula jaeschkeana, Ferula sinaica, and other organisms with data available. Ferutinin, a natural terpenoid compound, is an estrogen receptor ERα agonist and estrogen ERβ-receptor agonist/antagonist with IC50s of 33.1 nM and 180.5 nM, respectively. Ferutinin acts as an electrogenic Ca2+-ionophore that increases calcium permeability of lipid bilayer membranes, mitochondria. Ferutinin possesses estrogenic, antitumor, antibacterial and antiinflammatory activities[1][2].

(3S,4aS,10aS)-3-(Acetyloxy)-2,3,4,4a,10,10a-hexahydro-6-hydroxy-1,1,4a-trimethyl-7-(1-methylethyl)-9(1H)-phenanthrenone

2alpha-Acetoxysugiol is a natural product found in Salvia miltiorrhiza with data available.

Ilimaquinone

A natural product found in Dactylospongia elegans.

4-hydroxy-3-[(2E,6E)-4-hydroxy-3,7,11-trimethyldodeca-2,6,10-trienyl]benzoic acid

NCGC00169961-02!4-hydroxy-3-[(2E,6E)-4-hydroxy-3,7,11-trimethyldodeca-2,6,10-trienyl]benzoic acid

4-[4-(3,4-dimethoxyphenyl)-2,3-dimethylbutyl]-1,2-dimethoxybenzene

NCGC00384872-01!4-[4-(3,4-dimethoxyphenyl)-2,3-dimethylbutyl]-1,2-dimethoxybenzene

5-[10-(3,5-dihydroxyphenyl)decyl]benzene-1,3-diol

NCGC00381312-01!5-[10-(3,5-dihydroxyphenyl)decyl]benzene-1,3-diol

2-(2-hydroxy-6-methylhept-5-en-2-yl)-7-(3-methylbut-2-enyl)-2,3-dihydro-1-benzofuran-5-carboxylic acid

NCGC00179902-03!2-(2-hydroxy-6-methylhept-5-en-2-yl)-7-(3-methylbut-2-enyl)-2,3-dihydro-1-benzofuran-5-carboxylic acid

2-(2-hydroxy-6-methylhept-5-en-2-yl)-7-(3-methylbut-2-enyl)-2,3-dihydro-1-benzofuran-5-carboxylic acid

Yohimbic acid hydrate

canrenoic acid

3-[(8R,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3-oxo-2,3,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoic acid

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000451 - Mineralocorticoid Receptor Antagonists C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

4-[4-(3,4-dimethoxyphenyl)-2,3-dimethylbutyl]-1,2-dimethoxybenzene [IIN-based: Match]

NCGC00384872-01!4-[4-(3,4-dimethoxyphenyl)-2,3-dimethylbutyl]-1,2-dimethoxybenzene [IIN-based: Match]

4-hydroxy-3-[(2E,6E)-4-hydroxy-3,7,11-trimethyldodeca-2,6,10-trienyl]benzoic acid [IIN-based on: CCMSLIB00000847074]

NCGC00169961-02!4-hydroxy-3-[(2E,6E)-4-hydroxy-3,7,11-trimethyldodeca-2,6,10-trienyl]benzoic acid [IIN-based on: CCMSLIB00000847074]

2-(2-hydroxy-6-methylhept-5-en-2-yl)-7-(3-methylbut-2-enyl)-2,3-dihydro-1-benzofuran-5-carboxylic acid [IIN-based on: CCMSLIB00000848922]

NCGC00179902-03!2-(2-hydroxy-6-methylhept-5-en-2-yl)-7-(3-methylbut-2-enyl)-2,3-dihydro-1-benzofuran-5-carboxylic acid [IIN-based on: CCMSLIB00000848922]

2-(2-hydroxy-6-methylhept-5-en-2-yl)-7-(3-methylbut-2-enyl)-2,3-dihydro-1-benzofuran-5-carboxylic acid [IIN-based: Match]

NCGC00179902-03!2-(2-hydroxy-6-methylhept-5-en-2-yl)-7-(3-methylbut-2-enyl)-2,3-dihydro-1-benzofuran-5-carboxylic acid [IIN-based: Match]

4-hydroxy-3-[(2E,6E)-4-hydroxy-3,7,11-trimethyldodeca-2,6,10-trienyl]benzoic acid [IIN-based: Match]

NCGC00169961-02!4-hydroxy-3-[(2E,6E)-4-hydroxy-3,7,11-trimethyldodeca-2,6,10-trienyl]benzoic acid [IIN-based: Match]

4-hydroxy-3-[(2E,6E)-4-hydroxy-3,7,11-trimethyldodeca-2,6,10-trienyl]benzoic acid_major

Cafestol Acetate_major

cyclic 3,17-bis(1,2-ethanediyl acetal) estra-5(10),9(11)- diene-3,17-dione

Ala Ala Pro Thr

(2S,3R)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]propanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanoic acid

Ala Ala Thr Pro

(2S)-1-[(2S,3R)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

Ala Pro Ala Thr

(2S,3R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}propanamido]-3-hydroxybutanoic acid

Ala Pro Thr Ala

(2S)-2-[(2S,3R)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanamido]propanoic acid

Ala Thr Ala Pro

(2S)-1-[(2S)-2-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanamido]propanoyl]pyrrolidine-2-carboxylic acid

Ala Thr Pro Ala

(2S)-2-{[(2S)-1-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}propanoic acid

Canrenoate

Gly Pro Ser Val

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]-3-methylbutanoic acid

Gly Pro Val Ser

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-methylbutanamido]-3-hydroxypropanoic acid

Gly Ser Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

Gly Ser Val Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

Gly Val Pro Ser

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

Gly Val Ser Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-methylbutanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

Pro Ser Arg

Asp Lys Pro

Lys Asp Pro

Pro Asp Lys

Asp Pro Lys

Arg Ser Pro

Pro Ala Ala Thr

(2S,3R)-3-hydroxy-2-[(2S)-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]butanoic acid

Pro Ala Thr Ala

(2S)-2-[(2S,3R)-3-hydroxy-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanamido]propanoic acid

Pro Gly Ser Val

(2S)-2-[(2S)-3-hydroxy-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]-3-methylbutanoic acid

Pro Gly Val Ser

(2S)-3-hydroxy-2-[(2S)-3-methyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}butanamido]propanoic acid

Pro Ser Gly Val

(2S)-2-{2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}-3-methylbutanoic acid

Pro Ser Val Gly

2-[(2S)-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-methylbutanamido]acetic acid

Pro Thr Ala Ala

(2S)-2-[(2S)-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]propanoic acid

Pro Val Gly Ser

(2S)-3-hydroxy-2-{2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]acetamido}propanoic acid

Pro Val Ser Gly

2-[(2S)-3-hydroxy-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]acetic acid

Ser Pro Arg

Quinidine-10,11-dihydrodiol

Hydroquinine, 10,11-dihydroxy-

Ser Gly Pro Val

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-3-hydroxypropanamido]acetyl}pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

Ser Gly Val Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

Ser Pro Gly Val

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-methylbutanoic acid

Ser Pro Val Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]acetic acid

Ser Val Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylbutanamido]acetyl}pyrrolidine-2-carboxylic acid

Ser Val Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}acetic acid

Thr Ala Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]propanamido]propanoyl]pyrrolidine-2-carboxylic acid

Thr Ala Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]propanoyl]pyrrolidin-2-yl]formamido}propanoic acid

Ser Arg Pro

Thr Pro Ala Ala

(2S)-2-[(2S)-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}propanamido]propanoic acid

Val Gly Pro Ser

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-3-methylbutanamido]acetyl}pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

Val Gly Ser Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-3-methylbutanamido]acetamido}-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

Val Pro Gly Ser

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-hydroxypropanoic acid

Val Pro Ser Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]acetic acid

Val Ser Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxypropanamido]acetyl}pyrrolidine-2-carboxylic acid

Val Ser Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}acetic acid

7,8-epoxy-17S-HDHA

7,8-epoxy-17S-hydroxy-docosa-4Z,9E,11E,13Z,15E,19Z-hexaenoic acid

CAY10470

N4-[2-(4-phenoxyphenyl)ethyl]-4,6-quinazolinediamine

Salirasib

2-[[(2E,6E)-3,7,11-trimethyl-2,6,10-dodecatrien-1-yl]thio]-benzoic acid

D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1902 - Ras Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors Salirasib is a Ras inhibitor that inhibits specifically both oncogenically activated Ras and growth factor receptor-mediated Ras activation, resulting in the inhibition of Ras-dependent tumor growth.

tetramethyl Nordihydroguaiaretic Acid

4-[(2R,3S)-4-(3,4-dimethoxyphenyl)-2,3-dimethylbutyl]-1,2-dimethoxy-benzene

Terameprocol is a synthetic derivative of Nordihydroguaiaretic acid and a non-selective lipoxygenase inhibitor. Terameprocol has antiviral and antitumor effects[1][2][3].

4S-hydroxy-8-oxo-(5E,9Z,13Z,16Z,19Z)-neuroprostapentaenoic acid-cyclo[7S,11S]

7S,8S-epoxy-17S-HDHA

7S,8S-epoxy-17S-hydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid

7S,8S-epoxy-17R-HDHA

7S,8S-epoxy-17R-hydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid

Sorgoleone

2-hydroxy-5-methoxy-3-[(8E,11E)-pentadeca-8,11,14-trien-1-yl]cyclohexa-2,5-diene-1,4-dione

11,12-Dimethoxy-8,11,13-abietatrien-20,7-olide

3,4-dimethoxy-11,11-dimethyl-5-(propan-2-yl)-16-oxatetracyclo[6.6.2.0^{1,10}.0^{2,7}]hexadeca-2(7),3,5-trien-15-one

Piperoic acid

3,4-dihydroxy-5-[(2E,6Z)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]benzoic acid

FA 22:7;O2

3-((1R,5R)-5-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-4-oxocyclopent-2-en-1-yl)propanoic acid

Bendigole A

24-dinor-3-oxo,12alpha-hydroxy-chola-1,4-dien-22-oic acid

Lophachinin E

7R-acetoxy-dehydroabietic acid

Polycerasoidol

9-[(2R)-6-hydroxy-2,8-dimethyl-3,4-dihydrochromen-2-yl]-2,6-dimethylnona-2E,6E-dienoic acid

Palbinone

A natural product found in Paeonia rockii subspeciesrockii.

[5-(Cyclohexylamino)-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-1H-in dol-2-yl]boronic acid

TERT-BUTYL 5-METHYL-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-BENZO[D]IMIDAZOLE-1-CARBOXYLATE

PYRONINE B

C21H27ClN2O (358.1812)

19-Norpregna-5(10),9(11)-diene-3,20-dione, 17-hydroxy-cyclic 3-(1,2-ethanediyl acetal)

Anisopirol

C21H27FN2O2 (358.2056)

2,2-Thiobis(6-tert-butyl-p-cresol)

A-674563

(2s)-1-{[5-(3-Methyl-1h-Indazol-5-Yl)pyridin-3-Yl]oxy}-3-Phenylpropan-2-Amine

A-674563 is an orally active and selective Akt1 inhibitor with a Ki of 11 nM.

Belarizine

C24H26N2O (358.2045)

4-(trans-4-Propylcyclohexyl)-2,3-difluoro-4-ethoxy-1,1-biphenyl

C23H28F2O (358.2108)

2,2-diphenyl-4-piperidin-1-ylbutanamide,hydrochloride

C21H27ClN2O (358.1812)

DI-TERT-BUTYL(2,6-DIMETHOXY-[1,1-BIPHENYL]-2-YL)PHOSPHINE

C22H31O2P (358.2062)

Ronactolol

1,10-Bis(4-hydroxydiphenoxy)decane

METHYL 1,4-DI-BOC-PIPERAZINE-2-ACETATE

C17H30N2O6 (358.2104)

[1-[(2-methylpropan-2-yl)oxycarbonyl]-5-(piperidin-1-ylmethyl)indol-2-yl]boronic acid

Terameprocol

tetra-O-methyl nordihydroguaiaretic acid

C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor Terameprocol is a synthetic derivative of Nordihydroguaiaretic acid and a non-selective lipoxygenase inhibitor. Terameprocol has antiviral and antitumor effects[1][2][3].

2-Methyl-2-propanyl 2-benzyl-1,3-dioxo-2,8-diazaspiro[4.5]decane- 8-carboxylate

Acetyl fentanyl hydrochloride

C21H27ClN2O (358.1812)

Gestonorone acetate

4-METHYLUMBELLIFERYL LAURATE

1-N-BOC-3-METHYLINDAZOLE-5-BORONIC ACID PINACOL ESTER

4,4-Thio-bis(2-methyl-6-tert-butylphenol)

1-BOC-2-[(2-TRIFLUOROMETHYL-PHENYLAMINO)-METHYL]-PIPERIDINE

1-BOC-2-[(3-TRIFLUOROMETHYL-PHENYLAMINO)-METHYL]-PIPERIDINE

1-BOC-2-[(4-TRIFLUOROMETHYL-PHENYLAMINO)-METHYL]-PIPERIDINE

MK-0657

Rislenemdaz

C19H23FN4O2 (358.1805)

C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent Rislenemdaz (CERC-301) is an orally bioavailable and selective N-methyl-D-aspartate (NMDA) receptor subunit 2B (GluN2B) antagonist with Ki and IC 50 of 8.1 nM and 3.6 nM, respectively.

Hexaethylene glycol monophenyl ether

B-[3,5-Difluoro-4-(trans-4-propylcyclohexyl)[1,1-biphenyl]-4-yl]boronic acid

C21H25BF2O2 (358.1916)

7,8,9,10,18,19,20,21-Octahydro-6H,17H-dibenzo[b,k][1,4,10,13,7,16]tetraoxadiazacyclooctadecine

1,9-Diazaspiro[5.5]undecane, 1-(phenylmethyl)-, 2,2,2-trifluoroacetate (1:1)

buta-1,3-diene,ethyl prop-2-enoate,methyl 2-methylprop-2-enoate,styrene

GESTONORONE ACETATE:17ALPHA-ACETOXY-19-NORPREGN-4-EN-3,20-DIONE

Cimetropium

C21H28NO4+ (358.2018)

D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics

Cannabichromenic acid, (+)-

5-hydroxy-2-methyl-2-(4-methylpent-3-enyl)-7-pentylchromene-6-carboxylic acid

Diacetylspermine

C14H32Cl2N4O2 (358.1902)

Estra-1,3,5(10),16-tetraen-3-ol benzoate

C25H26O2 (358.1933)

3-Methoxy-16-methylestra-1,3,5(10)-triene-16beta,17beta-diol 17-acetate

17beta-Hydroxyandrost-4-ene-3,11-dione propionate

5-[(3s)-3-(2-Methoxybiphenyl-4-Yl)but-1-Yn-1-Yl]-6-Methylpyrimidine-2,4-Diamine

5-[(3r)-3-(5-Methoxybiphenyl-3-Yl)but-1-Yn-1-Yl]-6-Methylpyrimidine-2,4-Diamine

N2-[(Benzyloxy)carbonyl]-N1-[(3S)-1-cyanopyrrolidin-3-YL]-L-leucinamide

C19H26N4O3 (358.2005)

4-Hydroxy-3-(4-hydroxy-3,7,11-trimethyldodeca-2,6,10-trienyl)benzoic acid

xenovulene A

A sesquiterpenoid based on a humulene skeleton. It is isolated from Sarocladium strictum and has been shown to exhibit inhibitory activity against GABA receptor.

(S)-n-methyltetrahydropapaverine

C21H28NO4+ (358.2018)

3-[3-[(1E,3E,5Z,8Z,10E,12R,14Z)-12-hydroxyheptadeca-1,3,5,8,10,14-hexaenyl]oxiran-2-yl]propanoic acid

3-[3-[(1E,3E,5Z,8Z,10E,12S,14Z)-12-hydroxyheptadeca-1,3,5,8,10,14-hexaenyl]oxiran-2-yl]propanoic acid

(Z)-6-[3-[(1E,3E,5Z,7E,9R,11Z)-9-hydroxytetradeca-1,3,5,7,11-pentaenyl]oxiran-2-yl]hex-4-enoic acid

(6aR)-1-hydroxy-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromene-2-carboxylic acid

ferruginene B, (rel)-

A natural product found in Rhododendron ferrugineum.

ferruginene A, (rel)-

A natural product found in Rhododendron ferrugineum.

Myrsinoic acid C

A member of the class of chromanes that is 3,4-dihydro-2H-chromene substituted by a carboxy group at position 6, a hydroxy group at position 3, a methyl and a 4-methylpent-3-en-1-yl group at position 2 and a prenyl group at position 8 (the 2S,3S stereoisomer). Isolated from in Myrsine seguinii, it exhibits anti-inflammatory activity.

N4-[2-(4-phenoxyphenyl)ethyl]-1,2-dihydroquinazoline-4,6-diamine

Ala-Thr-Ala-Pro

A tetrapeptide composed of L-alanine, L-threonine, L-alanine, and L-proline joined in sequence by peptide linkages.

1-butyl-1-methyl-3-(12-oxo-7,8,9,10-tetrahydro-6H-azepino[2,1-b]quinazolin-2-yl)thiourea

C19H26N4OS (358.1827)

N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)propyl]-[1,2,4]triazolo[4,3-a]quinoxalin-4-amine

C21H22N6 (358.1906)

4-[[4-(2-Methoxyanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]-1-butanol

C18H26N6O2 (358.2117)

(1R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium

C21H28NO4+ (358.2018)

5-[(3,4-dimethylphenoxy)methyl]-N-methyl-N-(4-oxanylmethyl)-3-isoxazolecarboxamide

Trichosetin(1-)

C21H28NO4- (358.2018)

An organic anion resulting from the deprotonation of the enol moiety of trichosetin.

4S(5)-epoxy-17R-hydroxy-DHA

3-[[(1S,2R,4As,8aR)-1,2,4a-trimethyl-5-methylidene-3,4,6,7,8,8a-hexahydro-2H-naphthalen-1-yl]methyl]-2-hydroxy-5-methoxycyclohexa-2,5-diene-1,4-dione

(5S)-3-[(2E,6R,8E,10E,12E)-2,6-dimethyltetradeca-2,8,10,12-tetraenoyl]-5-(hydroxymethyl)pyrrolidine-2,4-dione

C21H28NO4- (358.2018)

Asp-Lys-Pro

Pro-Lys-Asp

Pro-Ser-Arg

3-Hydroxy-9-oxo-9,10-seco-23,24-bisnorchola-1,3,5(10)-trien-22-oic acid

[4-[1-(1-Cyclopentyl-5-tetrazolyl)propyl]-1-piperazinyl]-(2-furanyl)methanone

C18H26N6O2 (358.2117)

15-Ketoiloprost

(1R,5S)-7-[4-(2-fluorophenyl)phenyl]-3-(phenylmethyl)-3,6-diazabicyclo[3.1.1]heptane

C24H23FN2 (358.1845)

(1S,5R)-6-[(4-fluorophenyl)methyl]-7-(4-phenylphenyl)-3,6-diazabicyclo[3.1.1]heptane

C24H23FN2 (358.1845)

Ser-Pro-Arg

Asp-Pro-Lys

Pro-Asp-Lys

Arg-Pro-Ser

Arg-Ser-Pro

Lys-Asp-Pro

Lys-Pro-Asp

Pro-Arg-Ser

Ser-Arg-Pro

19-hydroxy-2,3-dinor-6-oxoprostaglandin F1alpha

A prostanoid that is 2,3-dinor-6-oxo-prostaglandin F1alpha in which a hydrogen at position 19 is replaced by a hydroxy group.

9alpha-Hydroxy-3-oxo-23,24-bisnorchola-1,4-dien-22-oic acid

(1S,2S,3E,7E,11E,13S)-13-Acetoxycembra-3,7,11,15-tetraen-17,2-olide

5-[10-(3,5-Dihydroxyphenyl)decyl]benzene-1,3-diol

N-Acetylglycylglycylisoleucylglycine methyl ester

Cyclic 3,17-bis(1,2-ethanediyl acetal) estra-5(10),9(11)-diene-3,17-dione

(1S,2S,6R,7R)-6-ethyl-1,6-dimethoxyspiro[10-oxa-5-azatricyclo[5.3.1.04,8]undecane-2,3-indole]-2-one

(2E,9E)-4-hydroxy-2,5,5,9-tetramethylcycloundeca-2,9-dien-1-yl 4-hydroxybenzoate

17-Hydroxy-3-oxo-17alpha-pregna-4,6-diene-21-carboxylic acid

Sorgoleone 358

(R)-laudanosine(1+)

C21H28NO4 (358.2018)

An organic cation that is the conjugate acid of (R)-laudanosine, obtained by protonation of the tertiary amino group; major species at pH 7.3.

4S(5)-epoxy-17R-hydroxydocosahexaenoic acid

An epoxy fatty acid that is (6E,8E,10Z,13Z,15E,19Z)-docosa-6,8,10,13,15,19-hexaenoic acid which is carrying an epoxy group at position 4S and a hydroxy group at position 17R. It is a metabolite of docosahexaenoic acid that can be converted to a D-resolvin.

4-epi-4-A4-NeuroP

7-epi-7-A4-NeuroP

7-epi-7-J4-NeuroP

13-epi-13-A4-NeuroP

13-epi-13-J4-NeuroP

14-epi-14-A4-NeuroP

17-epi-17-A4-NeuroP

20-epi-20-A4-NeuroP

11-epi-11-J4-NeuroP

ent-16-epi-13-J4-NeuroP

13,16-diepi-13-J4-NeuroP

delta(9)-Tetrahydrocannabinolic acid

A diterpenoid that is 6a,7,8,10a-tetrahydro-6H-benzo[c]chromene substituted at position 1 by a hydroxy group, positions 6, 6 and 9 by methyl groups and at position 3 by a pentyl group. A biosynthetic precursor to Delta(9)-tetrahydrocannabinol, the principal psychoactive constituent of the cannabis plant.

7S,8S-epoxy-17R-hydroxydocosahexaenoic acid

A hydroxydocosahexaenoic acid that is (4Z,9E,11E,13Z,15E,19Z)-docosa-4,9,11,13,15,19-hexaenoic acid carrying an epoxy group at position 7S and a hydroxy group at position 17R. It is a metabolite of docosahexaenoic acid, and serves as a precursor to D-resolvins.

Epoxy-HDHA

FAHFA 10:2/O-12:4

FAHFA 10:3/O-12:3

FAHFA 11:3/O-11:3

FAHFA 12:3/O-10:3

FAHFA 12:4/O-10:2

FAHFA 13:3/O-9:3

FAHFA 13:4/O-9:2

FAHFA 14:4/O-8:2

FAHFA 22:6;O

FAHFA 8:2/O-14:4

FAHFA 9:2/O-13:4

FAHFA 9:3/O-13:3

ST 18:0;O7

ST 18:0;O2;S

C18H30O5S (358.1814)

FTIDC

C18H23FN6O (358.1917)

FTIDC is an orally active, noncompetitive, selective allosteric metabotropic glutamate receptor (mGluR) 1 antagonist with an IC50 of 5.8 nM for human mGluR1a. FTIDC has no species differences in its antagonistic activity on recombinant human, mouse, and rat mGluR1[1].

8-(3,7-dimethylocta-2,6-dien-1-yl)-5-hydroxy-2,6,8-trimethyl-2,3-dihydro-1-benzopyran-4,7-dione

2-[(1s,6s)-6-[(3r)-3-hydroxypent-1-en-2-yl]-1,3,5-trimethylcyclohexa-2,4-dien-1-yl]-6-methoxy-3,5-dimethylpyran-4-one

[(3ar,15as)-10,14-dimethyl-3-methylidene-2-oxo-3ah,4h,7h,8h,11h,12h,15h,15ah-cyclotetradeca[b]furan-6-yl]methyl acetate

{6,14-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,12h,13h,15ah-cyclotetradeca[b]furan-10-yl}methyl acetate

(2r,3r,4r)-4-dodecyl-3-hydroxy-5-oxooxolane-2,3-dicarboxylic acid

(2r,8s)-8-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-5-hydroxy-2,6,8-trimethyl-2,3-dihydro-1-benzopyran-4,7-dione

3-{[(1s,2r,4ar,8ar)-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]methyl}-2-hydroxy-5-methoxycyclohexa-2,5-diene-1,4-dione

(1s,2r,3as,5r,8r,11s)-2,5,11-trimethyl-4,10-dioxo-8-(prop-1-en-2-yl)-1h,2h,3h,3ah,5h,8h,9h,11h-cyclopenta[11]annulen-1-yl acetate

3,6,9-trimethyl-1-(2-methylprop-1-en-1-yl)-7,10-dioxo-1h,2h,3h,3ah,4h,5h,6h,6ah-cyclopenta[e]naphthalen-8-yl acetate

2-[(1s,2s)-1-carboxy-2-methylbutyl]-5-hydroxy-5,7,7-trimethyl-9-oxo-5ah,6h-cyclopenta[g]isoquinolin-2-ium

[C21H28NO4]+ (358.2018)

2-{[(1r,4ar,8ar)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methyl}-3-hydroxy-5-(hydroxymethyl)cyclohexa-2,5-diene-1,4-dione

(2s,3s,4bs,8as)-2-ethenyl-2,4b,8,8-tetramethyl-4,10-dioxo-3,5,6,7,8a,9-hexahydro-1h-phenanthren-3-yl acetate

4-[(2s,3s)-4-(3,4-dimethoxyphenyl)-2,3-dimethylbutyl]-1,2-dimethoxybenzene

4-{3a,6,6,9a-tetramethyl-2,7-dioxo-hexahydro-1h-cyclopenta[a]naphthalen-3-ylidene}pent-2-enoic acid

6,10,14-trimethyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,12h,13h,15ah-cyclotetradeca[b]furan-9-yl acetate

(2s)-2-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-7-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzofuran-5-carboxylic acid

3-{[(1e,2s,8as)-2,5,5,8a-tetramethyl-hexahydro-2h-naphthalen-1-ylidene]methyl}-2,5,6-trihydroxybenzaldehyde

(1r,2s,3r)-3-[(1s,5r)-2-formyl-5-[(2z)-6-methylhepta-2,5-dien-2-yl]cyclopent-2-en-1-yl]-2-methyl-4-oxocyclopentyl acetate

7a,11-dihydroxy-9-(hydroxymethyl)-4,4,12b-trimethyl-1,2,3,4a,5,6,7,12-octahydrotetraphen-8-one

3-hydroxy-3-isopropyl-6,8a-dimethyl-1,2,3a,4,5,6-hexahydroazulen-4-yl 4-hydroxybenzoate

3-[(5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)methyl]-2-hydroxy-5-methoxycyclohexa-2,5-diene-1,4-dione

(6e,10e)-12-(5-hydroxy-2-methoxy-3-methylphenyl)-6,10-dimethyldodeca-6,10-diene-2,8-dione

(3s,4as,10ar,11ar,11bs)-4,4,8,11b-tetramethyl-9-oxo-1h,2h,3h,4ah,5h,6h,10ah,11h,11ah-phenanthro[3,2-b]furan-3-yl acetate

(2e)-3-[(1s,3r,4r,7r,8r,11s)-3-[(2z)-4-hydroxybut-2-en-2-yl]-4,6,8,10,11-pentamethyl-2-oxatricyclo[5.3.1.0⁴,¹¹]undeca-5,9-dien-8-yl]prop-2-enoic acid

tauranin

5,5,9-trimethyl-14-methylidene-11,15-dioxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-3-yl acetate

(1r,2r,3as,5r,8r,11r)-2,5,11-trimethyl-4,10-dioxo-8-(prop-1-en-2-yl)-1h,2h,3h,3ah,5h,8h,9h,11h-cyclopenta[11]annulen-1-yl acetate

(2e)-3-[(1r,3r,4r,7r,8r,11s)-3-[(2z)-but-2-en-2-yl]-10-(hydroxymethyl)-4,6,8,11-tetramethyl-2-oxatricyclo[5.3.1.0⁴,¹¹]undeca-5,9-dien-8-yl]prop-2-enoic acid

(1r,2s,3s,5r,10r)-5-ethenyl-2,5,11,11-tetramethyl-12-oxo-15-oxatetracyclo[8.4.1.0¹,¹⁰.0²,⁷]pentadec-13-en-3-yl acetate

7a-hydroxy-9-(hydroxymethyl)-4,4,12b-trimethyl-2,3,4a,5,6,7,11a,12-octahydro-1h-tetraphene-8,11-dione

(3r,3as,4s,8as)-3-hydroxy-3-isopropyl-6,8a-dimethyl-1,2,3a,4,5,8-hexahydroazulen-4-yl 4-hydroxybenzoate

2-hydroxy-5-methoxy-3-(pentadeca-8,11,14-trien-1-yl)cyclohexa-2,5-diene-1,4-dione

(5ar,7s,9as,9br)-1,7-dihydroxy-3a,3b,6,6,9a-pentamethyl-4h,5h,5ah,7h,8h,9h,9bh-cyclopenta[a]phenanthrene-2,3-dione

2-[6-(3-hydroxypent-1-en-2-yl)-1,3,5-trimethylcyclohexa-2,4-dien-1-yl]-6-methoxy-3,5-dimethylpyran-4-one

4-dodecyl-3-hydroxy-5-oxooxolane-2,3-dicarboxylic acid

2-[(5e)-2-hydroxy-6,10-dimethylundeca-5,9-dien-2-yl]-2,3-dihydro-1-benzofuran-5-carboxylic acid

6,10,14-trimethyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,12h,13h,15ah-cyclotetradeca[b]furan-12-yl acetate

2-{11-hydroxy-9a,11a-dimethyl-7-oxo-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}propanoic acid

(2s,6r)-2-{2-[(1r,3r)-1,3-dimethyl-2-methylidenecyclohexyl]ethyl}-6-methoxy-2-methyl-6,7-dihydrochromene-5,8-dione

(3r,5s,7s)-8-hydroxy-4,4,7-trimethyl-9-(2-methylbutanoyl)-3-(prop-1-en-2-yl)tricyclo[5.3.1.0¹,⁵]undec-8-ene-10,11-dione

(3r,5s,7r)-10-hydroxy-4,4,7-trimethyl-9-(2-methylbutanoyl)-3-(prop-1-en-2-yl)tricyclo[5.3.1.0¹,⁵]undec-9-ene-8,11-dione

(2s,4s,4as,8s,8as)-8-formyl-4-[2-(furan-3-yl)ethyl]-4a,8-dimethyl-3-methylidene-hexahydro-1h-naphthalen-2-yl acetate

(3ar,12r,15as)-6,10,14-trimethyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,12h,13h,15ah-cyclotetradeca[b]furan-12-yl acetate

3-{[(1e,2s,4as,8as)-2,5,5,8a-tetramethyl-hexahydro-2h-naphthalen-1-ylidene]methyl}-2-hydroxy-5-methoxycyclohexa-2,5-diene-1,4-dione

5,6-dihydroxy-2',5',5',8'a-tetramethyl-3',4',4'a,6',7',8'-hexahydro-2'h,3h-spiro[1-benzofuran-2,1'-naphthalene]-7-carbaldehyde

(1r,2r,3e,5s,8e)-5-hydroxy-2-isopropyl-5,9-dimethylcyclodeca-3,8-dien-1-yl 4-hydroxybenzoate

2-isopropyl-4b,8,8-trimethyl-1,4-dioxo-5,6,7,8a,9,10-hexahydrophenanthren-3-yl acetate

(3s,4r,5s,6s,7r)-4,5,6,7-tetrahydroxy-3-(1-hydroxydecyl)-4,5,6,7-tetrahydro-3h-2-benzofuran-1-one

19-acetoxy-15,16-epoxy-8(17),13(16),14-ent-labdatrien-20-al

{"Ingredient_id": "HBIN002163","Ingredient_name": "19-acetoxy-15,16-epoxy-8(17),13(16),14-ent-labdatrien-20-al","Alias": "NA","Ingredient_formula": "C22H30O4","Ingredient_Smile": "CC(=O)OCC1(CCCC2(C1CCC(=C)C2CCC3=COC=C3)C=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "187","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

20-hydroxydihydrorankinidine

{"Ingredient_id": "HBIN003409","Ingredient_name": "20-hydroxydihydrorankinidine","Alias": "NA","Ingredient_formula": "C20H26N2O4","Ingredient_Smile": "CCC1(CNC2CC3(C4CC1C2CO4)C5=CC=CC=C5N(C3=O)OC)O","Ingredient_weight": "358.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10009","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101606432","DrugBank_id": "NA"}

4-hydroxy-2,6,8-trimethyl-6-(3,7-dimethyl-2,6-octadienyl)-2h-1-benzopyran-5,7(3h,6h)-dione

{"Ingredient_id": "HBIN010437","Ingredient_name": "4-hydroxy-2,6,8-trimethyl-6-(3,7-dimethyl-2,6-octadienyl)-2h-1-benzopyran-5,7(3h,6h)-dione","Alias": "NA","Ingredient_formula": "C22H30O4","Ingredient_Smile": "CC1CC(=O)C2=C(O1)C(=C(C(C2=O)(C)CC=C(C)CCC=C(C)C)O)C","Ingredient_weight": "358.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10809","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "5318374","DrugBank_id": "NA"}

4-hydtoxy-2,6,8-trimethyl-6-(3,7-dimethyl-2,6-octadienyl)-2h-1-benzopyran-5,7(3h,6h)-dione

{"Ingredient_id": "HBIN010580","Ingredient_name": "4-hydtoxy-2,6,8-trimethyl-6-(3,7-dimethyl-2,6-octadienyl)-2h-1-benzopyran-5,7(3h,6h)-dione","Alias": "NA","Ingredient_formula": "C22H30O4","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31283","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

5-hydroxy-2,6,8-trimethyl-8-(3,7-dimethyl-2,6-octadienyl)-2h-1-benzopyran-4,7(3h,8h)-dione

{"Ingredient_id": "HBIN011587","Ingredient_name": "5-hydroxy-2,6,8-trimethyl-8-(3,7-dimethyl-2,6-octadienyl)-2h-1-benzopyran-4,7(3h,8h)-dione","Alias": "NA","Ingredient_formula": "C22H30O4","Ingredient_Smile": "CC1CC(=O)C2=C(O1)C(C(=O)C(=C2O)C)(C)CC=C(C)CCC=C(C)C","Ingredient_weight": "358.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10810","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "5318375","DrugBank_id": "NA"}

5-hydroxy-2,8,6-trimethyl-8-(3,7-dimethyl-2,6-octadienyl)-2h-1-betzopyran-4,7(3h,8h)-dione